Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 937746011000036110 | adalimumab 20 mg / 0.4 mL injection, 0.4 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 937747011000036113 | adalimumab 20 mg/0.4 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| adalimumab 20 mg/0.4 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.4 mL injection, syringe | Is a | adalimumab | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.4 mL injection, syringe | has intended active ingredient | adalimumab | true | Inferred relationship | Some | 1685197860 | |
| adalimumab 20 mg/0.4 mL injection, syringe | has Australian BoSS | adalimumab | true | Inferred relationship | Some | 1685197860 | |
| adalimumab 20 mg/0.4 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.4 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 1685197861 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amgevita 20 mg/0.4 mL injection, 0.4 mL syringe | Is a | True | adalimumab 20 mg/0.4 mL injection, syringe | Inferred relationship | Some | |
| adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe | has MPUU | True | adalimumab 20 mg/0.4 mL injection, syringe | Inferred relationship | Some | 1 |
| Abrilada 20 mg/0.4 mL injection, 0.4 mL syringe | Is a | True | adalimumab 20 mg/0.4 mL injection, syringe | Inferred relationship | Some | |
| Humira 20 mg/0.4 mL injection, 0.4 mL syringe | Is a | True | adalimumab 20 mg/0.4 mL injection, syringe | Inferred relationship | Some | |
| adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes | has MPUU | True | adalimumab 20 mg/0.4 mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR